Page last updated: 2024-08-16

technetium tc 99m sestamibi and Laryngeal Neoplasms

technetium tc 99m sestamibi has been researched along with Laryngeal Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Almadori, G; Corina, L; D'Andrea, G; Galli, J; Giordano, A; Samanes Gajate, AM	1
Dietz, A; Eisenhut, M; Haberkorn, U; Henze, M; Mier, W; Mohammed, A; Nollert, J; Rudat, V	1
Aktolun, C; Berk, F; Demir, H; Erdincler, O; Isgoren, S	1

Trials

1 trial(s) available for technetium tc 99m sestamibi and Laryngeal Neoplasms

Article	Year
Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile. European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:3 Topics: alpha-Methyltyrosine; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Iodine Radioisotopes; Laryngeal Neoplasms; Male; Middle Aged; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon	2002

Article

Year

Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile.

European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:3

Topics: alpha-Methyltyrosine; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Iodine Radioisotopes; Laryngeal Neoplasms; Male; Middle Aged; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon

2002

Other Studies

2 other study(ies) available for technetium tc 99m sestamibi and Laryngeal Neoplasms

Article	Year
[Use of SPECT with (99m)Tc-Sestamibi in a patient affected by laryngeal carcinoma and parathyroid adenoma]. Revista espanola de medicina nuclear, 2000, Volume: 19, Issue:3 Topics: Adenoma; Aged; Carcinoma, Squamous Cell; Humans; Hyperparathyroidism; Laryngeal Neoplasms; Laryngectomy; Male; Neoplasms, Multiple Primary; Parathyroid Neoplasms; Parathyroidectomy; Radiopharmaceuticals; Sodium Pertechnetate Tc 99m; Subtraction Technique; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon	2000
Tc-99m MDP and Tc-99m MIBI dual imaging of photopenic bone metastases of carcinoma of the larynx. Clinical nuclear medicine, 2002, Volume: 27, Issue:6 Topics: Bone Neoplasms; Carcinoma, Squamous Cell; False Negative Reactions; Femur; Humans; Ilium; Laryngeal Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi	2002

Article

Year

[Use of SPECT with (99m)Tc-Sestamibi in a patient affected by laryngeal carcinoma and parathyroid adenoma].

Revista espanola de medicina nuclear, 2000, Volume: 19, Issue:3

Topics: Adenoma; Aged; Carcinoma, Squamous Cell; Humans; Hyperparathyroidism; Laryngeal Neoplasms; Laryngectomy; Male; Neoplasms, Multiple Primary; Parathyroid Neoplasms; Parathyroidectomy; Radiopharmaceuticals; Sodium Pertechnetate Tc 99m; Subtraction Technique; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon

2000

Tc-99m MDP and Tc-99m MIBI dual imaging of photopenic bone metastases of carcinoma of the larynx.

Clinical nuclear medicine, 2002, Volume: 27, Issue:6

Topics: Bone Neoplasms; Carcinoma, Squamous Cell; False Negative Reactions; Femur; Humans; Ilium; Laryngeal Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi

2002